Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500112981Phase 4Recruiting
Phase 4, randomised, single-blind trial of esketamine in Postoperative sleep disturbance (PSD) (2 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoint: Sleep quality on the night after surgery. Started Nov 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500112981.